HomeAbout usHospitalsSearchLogin
Your medical data, safe and secure.
Name
GW 501516
Description
GW-501516 is a peroxisome proliferator-activator receptor-delta agonist for the potential treatment of dyslipidemia. It is developed by GlaxoSmithKline. This drug is in Phase II clinical trials .
No brand information found.
